Ginkgo Bioworks (DNA) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free DNA Stock Alerts $0.62 -0.04 (-6.02%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ginkgo Bioworks Short Interest DataCurrent Short Interest274,440,000 sharesPrevious Short Interest289,730,000 sharesChange Vs. Previous Month-5.28%Dollar Volume Sold Short$232.09 millionShort Interest Ratio7.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares2,211,280,000 sharesFloat Size1,390,000,000 sharesShort Percent of Float19.74%Today's Trading Volume69,412,049 sharesAverage Trading Volume32,721,748 sharesToday's Volume Vs. Average212% Short Selling Ginkgo Bioworks ? Sign up to receive the latest short interest report for Ginkgo Bioworks and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDNA Short Interest Over TimeDNA Days to Cover Over TimeDNA Percentage of Float Shorted Over Time Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. Ginkgo Bioworks Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024274,440,000 shares $232.09 million -5.3%19.7%7.2 $0.85 4/30/2024289,730,000 shares $258.18 million +8.7%20.8%9.4 $0.89 4/15/2024266,530,000 shares $253.76 million -1.6%19.7%10.8 $0.95 3/31/2024270,830,000 shares $314.16 million +3.3%20.2%12.2 $1.16 3/15/2024262,240,000 shares $283.22 million +2.6%19.6%11.9 $1.08 2/29/2024255,720,000 shares $391.25 million +2.2%19.1%11.2 $1.53 Get the Latest News and Ratings for DNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ginkgo Bioworks and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024250,230,000 shares $387.86 million +5.6%19.0%11.8 $1.55 1/31/2024236,910,000 shares $286.66 million +1.3%18.0%11.2 $1.21 1/15/2024233,850,000 shares $304.01 million -0.7%17.7%11.1 $1.30 12/31/2023235,500,000 shares $398.00 million -1.5%17.8%12.1 $1.69 12/15/2023239,070,000 shares $382.51 million +3.7%18.1%12.1 $1.60 11/30/2023230,480,000 shares $297.32 million +3.4%17.5%12.4 $1.29 11/15/2023222,910,000 shares $345.51 million -5.5%17.2%11.4 $1.55 10/31/2023235,940,000 shares $323.24 million +2.2%18.6%11.9 $1.37 10/15/2023230,820,000 shares $383.16 million -1.2%18.2%11.6 $1.66 9/30/2023233,540,000 shares $422.71 million -0.4%18.4%10.7 $1.81 9/15/2023234,530,000 shares $452.64 million +13.2%18.5%10.8 $1.93 8/31/2023207,170,000 shares $484.78 million +0.4%16.4%9 $2.34 8/15/2023206,330,000 shares $367.27 million -3.9%16.4%8.5 $1.78 7/31/2023214,590,000 shares $538.62 million -1.4%17.2%9.1 $2.51 7/15/2023217,710,000 shares $444.13 million -2.4%17.4%9.4 $2.04 6/30/2023223,020,000 shares $414.82 million +20.6%17.8%10.3 $1.86 6/15/2023184,920,000 shares $361.52 million +0.9%14.8%8.7 $1.96 5/31/2023183,290,000 shares $289.60 million -9.4%14.7%9.1 $1.58 5/15/2023202,240,000 shares $266.96 million +7.5%16.2%10.1 $1.32 4/30/2023188,130,000 shares $229.52 million -4.4%15.3%10 $1.22 4/15/2023196,750,000 shares $255.78 million +2.1%16.7%10.2 $1.30 3/31/2023192,710,000 shares $256.30 million +11.3%19.1%9.7 $1.33 3/15/2023173,100,000 shares $230.22 million +18.4%17.1%8.3 $1.33 2/28/2023146,150,000 shares $214.84 million +16.8%14.5%6.8 $1.47 2/15/2023125,180,000 shares $227.83 million +1.4%12.4%5.9 $1.82 1/31/2023123,490,000 shares $240.81 million -1.6%12.1%5.3 $1.95 1/15/2023125,510,000 shares $233.45 million -0.6%12.4%5.3 $1.86 12/30/2022126,250,000 shares $213.36 million +10.5%12.5%5.2 $1.69 12/15/2022114,290,000 shares $186.29 million -3.6%11.0%4.5 $1.63 11/30/2022118,570,000 shares $235.95 million -4.7%12.6%4.8 $1.99 11/15/2022124,380,000 shares $332.09 million -7.3%13.2%5 $2.67 10/31/2022134,220,000 shares $366.42 million -14.1%15.7%4.9 $2.73 10/15/2022156,300,000 shares $404.82 million -8.8%19.2%5.9 $2.59 9/30/2022171,280,000 shares $534.39 million -8.7%24.2%6.8 $3.12He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here 9/15/2022187,610,000 shares $587.22 million +4.8%22.1%7.4 $3.13 8/31/2022179,060,000 shares $481.67 million +24.1%22.8%7 $2.69 8/15/2022144,250,000 shares $503.43 million -4.0%18.4%5.5 $3.49 7/31/2022150,270,000 shares $429.77 million +3.9%19.8%6.5 $2.86 7/15/2022144,640,000 shares $433.92 million +7.5%19.1%6.2 $3.00 6/30/2022134,540,000 shares $320.21 million +22.4%17.8%5.7 $2.38 6/15/2022109,920,000 shares $284.69 million -14.7%14.6%4.3 $2.59 5/31/2022128,780,000 shares $396.64 million +19.1%17.1%5.6 $3.08 5/15/2022108,160,000 shares $287.71 million +16.9%14.4%5.2 $2.66 4/30/202292,500,000 shares $268.25 million +13.8%11.8%5 $2.90 4/15/202281,300,000 shares $312.19 million +9.7%10.3%4.6 $3.84 3/31/202274,120,000 shares $298.70 million -16.4%9.4%4.4 $4.03 3/15/202288,670,000 shares $258.03 million +2.9%9.3%7.1 $2.91 2/28/202286,190,000 shares $387.86 million +1.5%9.4%7.3 $4.50 2/15/202284,950,000 shares $471.47 million -9.2%9.2%7.5 $5.55 1/31/202293,570,000 shares $559.55 million +30.3%10.2%8.9 $5.98 1/15/202271,830,000 shares $415.90 million +30.0%8.6%8.2 $5.79 12/31/202155,270,000 shares $459.29 million No Change6.4%7 $8.31 DNA Short Interest - Frequently Asked Questions What is Ginkgo Bioworks' current short interest? Short interest is the volume of Ginkgo Bioworks shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 274,440,000 shares of DNA short. 19.74% of Ginkgo Bioworks' shares are currently sold short. Learn More on Ginkgo Bioworks' current short interest. What is a good short interest ratio for Ginkgo Bioworks? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DNA shares currently have a short interest ratio of 7.0. Learn More on Ginkgo Bioworks's short interest ratio. Which institutional investors are shorting Ginkgo Bioworks? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ginkgo Bioworks: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ginkgo Bioworks? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.74% of Ginkgo Bioworks' floating shares are currently sold short. Is Ginkgo Bioworks' short interest increasing or decreasing? Ginkgo Bioworks saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 274,440,000 shares, a drop of 5.3% from the previous total of 289,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ginkgo Bioworks' float size? Ginkgo Bioworks currently has issued a total of 2,211,280,000 shares. Some of Ginkgo Bioworks' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ginkgo Bioworks currently has a public float of 1,390,000,000 shares. How does Ginkgo Bioworks' short interest compare to its competitors? 19.74% of Ginkgo Bioworks' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Ginkgo Bioworks: Halozyme Therapeutics, Inc. (6.80%), CRISPR Therapeutics AG (18.05%), Krystal Biotech, Inc. (9.84%), ImmunityBio, Inc. (38.03%), Immunovant, Inc. (15.25%), SpringWorks Therapeutics, Inc. (14.43%), Apogee Therapeutics, Inc. (12.30%), Iovance Biotherapeutics, Inc. (22.90%), Arcellx, Inc. (9.67%), Denali Therapeutics Inc. (8.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Ginkgo Bioworks stock? Short selling DNA is an investing strategy that aims to generate trading profit from Ginkgo Bioworks as its price is falling. DNA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ginkgo Bioworks? A short squeeze for Ginkgo Bioworks occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DNA, which in turn drives the price of the stock up even further. How often is Ginkgo Bioworks' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DNA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Halozyme Therapeutics Short Interest Data CRISPR Therapeutics Short Interest Data Krystal Biotech Short Interest Data ImmunityBio Short Interest Data Immunovant Short Interest Data SpringWorks Therapeutics Short Interest Data Apogee Therapeutics Short Interest Data Iovance Biotherapeutics Short Interest Data Arcellx Short Interest Data Denali Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:DNA) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ginkgo Bioworks Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.